Quantinuum Inc. (QNT)

Quantinuum Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2025	Dec 31, 2024
Revenue	17.08	30.93	22.98
Revenue Growth (YoY)	-	34.61%	-
Cost of Revenue	-	4.73	10.81
Gross Profit	12.71	26.2	12.17
Selling, General & Admin	-	48.72	31.33
Research & Development	-	165.42	122.24
Other Operating Expenses	0	11.36	11.36
Operating Expenses	-	225.5	164.93
Operating Income	-246.57	-199.3	-152.75
Interest Expense (Income)	-16.1	-12.68	-10.03
Other Expense (Income)	68.26	5.87	1.11
Pretax Income	-298.73	-192.49	-143.84
Income Tax	-0.06	0.08	0.23
Net Income	-298.67	-192.56	-144.07
Free Cash Flow	-272.75	-235.35	-134.89
Gross Margin	74.38%	84.71%	52.97%
Operating Margin	-1443.35%	-644.32%	-664.75%
Profit Margin	-1748.32%	-622.55%	-626.97%
Free Cash Flow Margin	-1596.62%	-760.89%	-587.02%
EBITDA	-283.49	-175.39	-121.64
EBITDA Margin	-1659.47%	-567.05%	-529.34%
Depreciation & Amortization	31.34	29.78	32.23
EBIT	-314.83	-205.17	-153.86
EBIT Margin	-1842.93%	-663.31%	-669.58%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).